Cargando…

Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis

International policy for treatment of multidrug- and rifampin-resistant tuberculosis (MDR/RR TB) relies largely on individual patient data (IPD) from observational studies of patients treated under routine conditions. We prepared guidance on which data to collect and what measures could improve cons...

Descripción completa

Detalles Bibliográficos
Autores principales: Campbell, Jonathon R., Falzon, Dennis, Mirzayev, Fuad, Jaramillo, Ernesto, Migliori, Giovanni Battista, Mitnick, Carole D., Ndjeka, Norbert, Menzies, Dick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045826/
https://www.ncbi.nlm.nih.gov/pubmed/31922953
http://dx.doi.org/10.3201/eid2603.190997
_version_ 1783501852111798272
author Campbell, Jonathon R.
Falzon, Dennis
Mirzayev, Fuad
Jaramillo, Ernesto
Migliori, Giovanni Battista
Mitnick, Carole D.
Ndjeka, Norbert
Menzies, Dick
author_facet Campbell, Jonathon R.
Falzon, Dennis
Mirzayev, Fuad
Jaramillo, Ernesto
Migliori, Giovanni Battista
Mitnick, Carole D.
Ndjeka, Norbert
Menzies, Dick
author_sort Campbell, Jonathon R.
collection PubMed
description International policy for treatment of multidrug- and rifampin-resistant tuberculosis (MDR/RR TB) relies largely on individual patient data (IPD) from observational studies of patients treated under routine conditions. We prepared guidance on which data to collect and what measures could improve consistency and utility for future evidence-based recommendations. We highlight critical stages in data collection at which improvements to uniformity, accuracy, and completeness could add value to IPD quality. Through a repetitive development process, we suggest essential patient- and treatment-related characteristics that should be collected by prospective contributors of observational IPD in MDR/RR TB.
format Online
Article
Text
id pubmed-7045826
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-70458262020-03-07 Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis Campbell, Jonathon R. Falzon, Dennis Mirzayev, Fuad Jaramillo, Ernesto Migliori, Giovanni Battista Mitnick, Carole D. Ndjeka, Norbert Menzies, Dick Emerg Infect Dis Online Report International policy for treatment of multidrug- and rifampin-resistant tuberculosis (MDR/RR TB) relies largely on individual patient data (IPD) from observational studies of patients treated under routine conditions. We prepared guidance on which data to collect and what measures could improve consistency and utility for future evidence-based recommendations. We highlight critical stages in data collection at which improvements to uniformity, accuracy, and completeness could add value to IPD quality. Through a repetitive development process, we suggest essential patient- and treatment-related characteristics that should be collected by prospective contributors of observational IPD in MDR/RR TB. Centers for Disease Control and Prevention 2020-03 /pmc/articles/PMC7045826/ /pubmed/31922953 http://dx.doi.org/10.3201/eid2603.190997 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Online Report
Campbell, Jonathon R.
Falzon, Dennis
Mirzayev, Fuad
Jaramillo, Ernesto
Migliori, Giovanni Battista
Mitnick, Carole D.
Ndjeka, Norbert
Menzies, Dick
Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis
title Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis
title_full Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis
title_fullStr Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis
title_full_unstemmed Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis
title_short Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis
title_sort improving quality of patient data for treatment of multidrug- or rifampin-resistant tuberculosis
topic Online Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045826/
https://www.ncbi.nlm.nih.gov/pubmed/31922953
http://dx.doi.org/10.3201/eid2603.190997
work_keys_str_mv AT campbelljonathonr improvingqualityofpatientdatafortreatmentofmultidrugorrifampinresistanttuberculosis
AT falzondennis improvingqualityofpatientdatafortreatmentofmultidrugorrifampinresistanttuberculosis
AT mirzayevfuad improvingqualityofpatientdatafortreatmentofmultidrugorrifampinresistanttuberculosis
AT jaramilloernesto improvingqualityofpatientdatafortreatmentofmultidrugorrifampinresistanttuberculosis
AT migliorigiovannibattista improvingqualityofpatientdatafortreatmentofmultidrugorrifampinresistanttuberculosis
AT mitnickcaroled improvingqualityofpatientdatafortreatmentofmultidrugorrifampinresistanttuberculosis
AT ndjekanorbert improvingqualityofpatientdatafortreatmentofmultidrugorrifampinresistanttuberculosis
AT menziesdick improvingqualityofpatientdatafortreatmentofmultidrugorrifampinresistanttuberculosis